Breaking News: New Data Released
New phase 3 clinical trial data examining etripamil, Milestone’s investigational drug for PSVT.
OUR AREAS OF FOCUS
Delivering Cardiac Peace of Mind
We focus on developing treatments for self-administration outside of the emergency department or hospital setting for patients with acute episodes of paroxysmal supraventricular tachycardia (PSVT) and atrial fibrillation (AFib), as well as other episodic cardiovascular conditions.
Paroxysmal
Supraventricular
Tachychardia
(PSVT)
Atrial Fibrillation
with Rapid Ventricular Rate
(AFib-RVR)
Other Episodic CV Conditions
OUR AREAS OF FOCUS
Delivering Cardiac Peace of Mind
Our focus is to fill the existing gap in therapy for the rapid termination of paroxysmal supraventricular tachycardia (PSVT) and other episodic cardiovascular conditions, including atrial fibrillation and angina, outside of the emergency department or hospital setting.
OUR PIPELINE
Developing Novel Therapies for Cardiovascular Conditions
We are developing our investigational product etripamil, a novel, non-dihydropyridine calcium channel blocker delivered as a nasal spray, for the acute at-home treatment of patients living with the heart rhythm disturbances of PSVT and AFib, as well as other episodic cardiovascular conditions—wherever you are when they occur.
OUR PIPELINE
Developing Novel Therapies for Cardiovascular Conditions
We are developing our investigational product etripamil, a novel, non-dihydropyridine calcium channel blocker delivered as a nasal spray, for the acute at-home treatment of patients living with the heart rhythm disturbances of PSVT and AFib, as well as other episodic cardiovascular conditions—wherever you are when they occur.
OUR PUBLICATIONS
Profiling PSVT and AFib
Our published studies analyze the physical, financial, and emotional burden of acute episodes of PSVT and AFib, to both individuals and our healthcare system at large.
CLINICAL TRIALS
Our Heartfelt Thanks
We know that advancing scientific discovery is not possible without dedicated patient volunteers and researchers working together. Talking to your healthcare team can help you know whether a clinical trial is right for you and determine whether you are eligible to participate in our clinical trials.
CLINICAL TRIALS
Our Heartfelt Thanks
We know that advancing scientific discovery is not possible without dedicated patient volunteers and researchers working together. Talking to your healthcare team can help you know whether a clinical trial is right for you and determine whether you are eligible to participate in our clinical trials.
.png){kind=small}